The tobacco product landscape is evolving and the AACR Tobacco Products and Cancer Subcommittee has been cognizant of the shift from combusted products (e.g., cigarettes) to alternative nicotine delivery systems, such as e-cigarettes. While...
Metastasis is defined as the spreading of cancer cells from the place where they first formed to another part of the body. Once cancer has metastasized, it can become more difficult to treat, increasing...
On Saturday, May 4, Philadelphians flooded the Benjamin Franklin Parkway for the Franklin Institute’s ninth annual Philadelphia Science Festival. For the fourth consecutive year, the American Association for Cancer Research (AACR) was a sponsor...
Since the 1990s, the cancer mortality rate in the U.S. has steadily declined. Yet liver cancer death rates in the U.S. have increased. Why? Liver cancer is caused principally by the combination of a chronic...
A large study of postmenopausal women showed strong benefit from smoking cessation in lowering the risk of bladder cancer. Bladder cancer is the most common malignancy of the urinary system. Some 80,470 new diagnoses...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased the number of treatment options for certain patients with bladder, lung, and kidney cancer. On...
The Fifth AACR New Horizons in Cancer Research (NHiCR) international conference has concluded, and the more than 400 attendees are en route to their home countries, which included Australia, China, Colombia, Germany, Israel, Japan,...
Shenzhen is a remarkable place. It serves as a gateway to Hong Kong, and in its short 40-year history has grown to become China’s seventh largest city, with a population of 20 million and some...
Greetings from Shenzhen, China, where the Fifth AACR New Horizons in Cancer Research (NHiCR) Conference is now underway. The event’s aim is to create and further a global forum for the communication and exchange of...
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum to present and discuss the latest breakthroughs in cutting-edge basic, translational, and clinical cancer research....
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More